For: | Toita R, Kawano T, Kang JH, Murata M. Applications of human hepatitis B virus preS domain in bio- and nanotechnology. World J Gastroenterol 2015; 21(24): 7400-7411 [PMID: 26139986 DOI: 10.3748/wjg.v21.i24.7400] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v21/i24/7400.htm |
Number | Citing Articles |
1 |
Xiaodan Cai, Weihao Zheng, Shaokun Pan, Shengyuan Zhang, Youhua Xie, Haitao Guo, Guoxin Wang, Zigang Li, Ming Luo. A virus-like particle of the hepatitis B virus preS antigen elicits robust neutralizing antibodies and T cell responses in mice. Antiviral Research 2018; 149: 48 doi: 10.1016/j.antiviral.2017.11.007
|
2 |
Yongpeng Wang, Guy Sedar Singor Njateng, Tianrui Zhao, Meilian Yang, Yifen Wang, Jianxin Cao, Yaping Liu, Guiguang Cheng. Evaluation of Acute and Subacute Toxicity of Two Different Extracts from Que Zui Tea in Rats. eFood 2021; 2(2): 81 doi: 10.2991/efood.k.210329.002
|
3 |
J. Rajčáni, S. Szathmary. Peptide Vaccines: New Trends for Avoiding the Autoimmune Response. The Open Infectious Diseases Journal 2018; 10(1): 47 doi: 10.2174/1874279301810010047
|
4 |
Huizhen Sun, Le Chang, Ying Yan, Lunan Wang. Hepatitis B virus pre‐S region: Clinical implications and applications. Reviews in Medical Virology 2021; 31(4) doi: 10.1002/rmv.2201
|
5 |
Fengping Jiao, Lu Long, Shanlong Ding, Xiaomeng Xie, Le Jia, Fengmin Lu. Complete genome sequencing and clinical analysis of intrahepatic hepatitis B virus cccDNA from HCC. Microbial Pathogenesis 2017; 109: 49 doi: 10.1016/j.micpath.2017.04.028
|
6 |
Shengdi Li, Zhen Wang, Yixue Li, Guohui Ding. Adaptive evolution of proteins in hepatitis B virus during divergence of genotypes. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-02012-8
|
7 |
Tara Vinyette Saco, Alexandra T. Strauss, Dennis K. Ledford. Hepatitis B vaccine nonresponders. Annals of Allergy, Asthma & Immunology 2018; 121(3): 320 doi: 10.1016/j.anai.2018.03.017
|